FAM103A1 Inhibitors
FAM103A1 inhibitors represent a specialized group of chemical agents designed to selectively interfere with the functional activity of the FAM103A1 protein, a protein that has been implicated in various cellular processes. While the exact biological function of FAM103A1 remains to be fully elucidated, these inhibitors target the signaling pathways and biochemical interactions in which FAM103A1 is a critical participant. The design of FAM103A1 inhibitors is based on the premise of interrupting the protein's activity at a molecular level, thereby hindering its role in cellular mechanisms. This class of inhibitors is often characterized by their ability to bind to the active or allosteric sites of FAM103A1, leading to a conformational change or steric hindrance that reduces the protein's activity. The specificity of these inhibitors is paramount to ensure that they do not inadvertently disrupt other proteins with similar structures or functions.
The development of FAM103A1 inhibitors involves a deep understanding of the protein's structure and the pathways it influences. Researchers typically employ techniques such as molecular docking and structure-activity relationship studies to identify potential compounds that exhibit the desired inhibitory effect. Once identified, these compounds are subjected to a series of biochemical assays to confirm their efficacy in inhibiting FAM103A1. The compounds in this class are evaluated for their selectivity, ensuring that they do not interfere with other proteins and thus maintain a favorable safety profile. By focusing on the unique aspects of FAM103A1's involvement in cellular processes, FAM103A1 inhibitors are crafted to be as targeted as possible, providing a precise approach to modulating the function of this protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
A mTOR inhibitor that impedes the mTOR pathway, crucial for protein synthesis and cellular growth, indirectly affecting the stability of FAM103A1 by reducing the overall rate of protein synthesis which could lead to a reduced expression of FAM103A1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that disrupts the PI3K/AKT/mTOR signaling axis, leading to the inhibition of downstream targets including FAM103A1 by reducing the phosphorylation events required for its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that prevents the activation of MAPK/ERK pathway, potentially decreasing the phosphorylation and, hence, the activity of FAM103A1 if it is involved in this signaling route. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor that, like PD98059, targets the MAPK/ERK pathway, potentially reducing the functional activity of FAM103A1 through decreased phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that might indirectly reduce the activity of FAM103A1 by blocking the pathways that phosphorylate proteins downstream or upstream of FAM103A1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK signaling which could alter the phosphorylation state and function of FAM103A1 if it is part of JNK-mediated cellular responses. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor which can downregulate the ERBB signaling pathway, potentially leading to a reduction in FAM103A1 activity if it is downstream of this pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that may influence cellular contraction and motility processes that are potentially regulated by FAM103A1, leading to its functional inhibition. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could lead to the accumulation of misfolded proteins, indirectly affecting the stability and function of FAM103A1 by disrupting the cellular proteostasis network. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
An inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) that disrupts calcium homeostasis, potentially impacting FAM103A1 function as cellular calcium levels are crucial for many signaling pathways. | ||||||